Eric Karas
Chief Commercial Officer
Other
Executive changes
Earnings-call appearances
-
ARS Pharmaceuticals, Inc. Q4 FY2025 Earnings Call2026-03-09
ARS Pharmaceuticals, Inc. (SPRY)
-
ARS Pharmaceuticals, Inc. Q3 FY2025 Earnings Call2025-11-10
ARS Pharmaceuticals, Inc. (SPRY)
-
ARS Pharmaceuticals, Inc. Q2 FY2025 Earnings Call2025-08-13
ARS Pharmaceuticals, Inc. (SPRY)
-
ARS Pharmaceuticals, Inc. Q1 FY2025 Earnings Call2025-05-14
ARS Pharmaceuticals, Inc. (SPRY)
-
ARS Pharmaceuticals, Inc. Q4 FY2024 Earnings Call2025-03-20
ARS Pharmaceuticals, Inc. (SPRY)
-
ARS Pharmaceuticals, Inc. Q3 FY2024 Earnings Call2024-11-13
ARS Pharmaceuticals, Inc. (SPRY)